ArticleSage open pathology
Chemotherapy Associated Nonocclusive Mesenteric Ischemia During Chemoradiation Therapy for Esophageal Cancer: A Case Report.
Article in Sage open pathology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nonocclusive mesenteric ischemia (NOMI) is a type of intestinal ischemia without organic vascular obstruction that carries high mortality rates, making it a critical condition with a poor prognosis. This report describes a case involving a 71-year-old man with esophageal cancer who developed NOMI during chemoradiation therapy. After initiation of chemoradiation therapy with combined 5-fluorouracil and cisplatin, the patient experienced acute abdominal pain and hypotension. Imaging findings suggested NOMI of the distal ileum. Early intervention rapidly decreased his symptoms and improved his vital signs, thereby avoiding surgical treatment. Thus, the patient received conservative treatment and completed his radiation therapy as scheduled without recurrence of symptoms, although chemotherapy was discontinued. To our knowledge, this is the first reported case of chemotherapy-associated NOMI successfully managed with conservative treatment alone, highlighting the potential effectiveness of early therapeutic intervention before the condition progresses to severe ischemia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.